Your browser doesn't support javascript.
loading
A chemical probe to modulate human GID4 Pro/N-degron interactions.
Owens, Dominic D G; Maitland, Matthew E R; Khalili Yazdi, Aliakbar; Song, Xiaosheng; Reber, Viviane; Schwalm, Martin P; Machado, Raquel A C; Bauer, Nicolas; Wang, Xu; Szewczyk, Magdalena M; Dong, Cheng; Dong, Aiping; Loppnau, Peter; Calabrese, Matthew F; Dowling, Matthew S; Lee, Jisun; Montgomery, Justin I; O'Connell, Thomas N; Subramanyam, Chakrapani; Wang, Feng; Adamson, Ella C; Schapira, Matthieu; Gstaiger, Matthias; Knapp, Stefan; Vedadi, Masoud; Min, Jinrong; Lajoie, Gilles A; Barsyte-Lovejoy, Dalia; Owen, Dafydd R; Schild-Poulter, Caroline; Arrowsmith, Cheryl H.
Afiliación
  • Owens DDG; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Maitland MER; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Khalili Yazdi A; Robarts Research Institute, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
  • Song X; Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
  • Reber V; Don Rix Protein Identification Facility, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
  • Schwalm MP; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Machado RAC; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Bauer N; Institute of Molecular Systems Biology at ETH Zurich, Zurich, Switzerland.
  • Wang X; Institut für Pharmazeutische Chemie, Goethe-University Frankfurt, Biozentrum, Frankfurt am Main, Germany.
  • Szewczyk MM; Structural Genomics Consortium, Goethe-University Frankfurt, Buchmann Institute for Life Sciences, Frankfurt am Main, Germany.
  • Dong C; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Dong A; Institut für Pharmazeutische Chemie, Goethe-University Frankfurt, Biozentrum, Frankfurt am Main, Germany.
  • Loppnau P; Structural Genomics Consortium, Goethe-University Frankfurt, Buchmann Institute for Life Sciences, Frankfurt am Main, Germany.
  • Calabrese MF; Robarts Research Institute, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
  • Dowling MS; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Lee J; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Montgomery JI; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • O'Connell TN; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Subramanyam C; Development and Medical, Pfizer Worldwide Research, Groton, CT, USA.
  • Wang F; Development and Medical, Pfizer Worldwide Research, Groton, CT, USA.
  • Adamson EC; Development and Medical, Pfizer Worldwide Research, Groton, CT, USA.
  • Schapira M; Development and Medical, Pfizer Worldwide Research, Groton, CT, USA.
  • Gstaiger M; Development and Medical, Pfizer Worldwide Research, Groton, CT, USA.
  • Knapp S; Development and Medical, Pfizer Worldwide Research, Groton, CT, USA.
  • Vedadi M; Development and Medical, Pfizer Worldwide Research, Groton, CT, USA.
  • Min J; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Lajoie GA; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Barsyte-Lovejoy D; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
  • Owen DR; Institute of Molecular Systems Biology at ETH Zurich, Zurich, Switzerland.
  • Schild-Poulter C; Institut für Pharmazeutische Chemie, Goethe-University Frankfurt, Biozentrum, Frankfurt am Main, Germany.
  • Arrowsmith CH; Structural Genomics Consortium, Goethe-University Frankfurt, Buchmann Institute for Life Sciences, Frankfurt am Main, Germany.
Nat Chem Biol ; 2024 May 21.
Article en En | MEDLINE | ID: mdl-38773330
ABSTRACT
The C-terminal to LisH (CTLH) complex is a ubiquitin ligase complex that recognizes substrates with Pro/N-degrons via its substrate receptor Glucose-Induced Degradation 4 (GID4), but its function and substrates in humans remain unclear. Here, we report PFI-7, a potent, selective and cell-active chemical probe that antagonizes Pro/N-degron binding to human GID4. Use of PFI-7 in proximity-dependent biotinylation and quantitative proteomics enabled the identification of GID4 interactors and GID4-regulated proteins. GID4 interactors are enriched for nucleolar proteins, including the Pro/N-degron-containing RNA helicases DDX21 and DDX50. We also identified a distinct subset of proteins whose cellular levels are regulated by GID4 including HMGCS1, a Pro/N-degron-containing metabolic enzyme. These data reveal human GID4 Pro/N-degron targets regulated through a combination of degradative and nondegradative functions. Going forward, PFI-7 will be a valuable research tool for investigating CTLH complex biology and facilitating development of targeted protein degradation strategies that highjack CTLH E3 ligase activity.

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article